General
Preferred name
AM404
Synonyms
AM 404 ()
AM-404 ()
P&D ID
PD003151
CAS
198022-70-7
183718-77-6
Tags
available
drug candidate
Drug indication
Discovery agent
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
A bioactive metabolite of that is proposed to mediate the central antinociceptive effects of the drug .
(GtoPdb)
DESCRIPTION
Anandamide transport inhibitor
(Tocriscreen Total)
DESCRIPTION
AM404 is an endocannabinoid reuptake inhibitor, a TRPV(1) activator, a paracetamol metabolite, with neuroprotective and anticancer activity that blocks anandamide transport. AM404 inhibits NFAT and NF-kappaB signaling pathways and impairs migration and invasiveness of neuroblastoma cells, preventing prostaglandin synthesis in activated microglia by inhibiting COX activity.
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
1
Organisms
3
Compound Sets
8
Cayman Chemical Bioactives
Drug Repurposing Hub
DrugMAP
Guide to Pharmacology
NIH Clinical Collections (NCC)
Probe Miner (suitable probes)
TargetMol Bioactive Compound Library
Tocriscreen Total
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
49
Molecular Weight
395.28
Hydrogen Bond Acceptors
2
Hydrogen Bond Donors
2
Rotatable Bonds
15
Ring Count
1
Aromatic Ring Count
1
cLogP
7.48
TPSA
49.33
Fraction CSP3
0.42
Chiral centers
0.0
Largest ring
6.0
QED
0.18
Structural alerts
2
aggregator (Aggregator Advisor)
Aggregators
aggregator (ZINC)
Aggregators
Custom attributes
(extracted from source data)
Target
TRPV1
Endocannabinoid reuptake
CNR1, CNR2, FAAH, TRPV1
MOA
cyclooxygenase inhibitor, FAAH inhibitor, TRPV antagonist
Pathway
GPCR/G protein
Membrane Transporter/Ion Channel
Source data

